Sept 09, 2021
AccurEdit Raises Tens of Millions of Dollars in Seed Funding
AccurEdit Therapeutics (Suzhou) Co., Ltd. ("AccurEdit ") announced today that it had raised tens of millions of dollars in seed funding. The funding round was led by Legend Capital, a world-renowned medical investment institution, with participation from Cormorant. The raised fund will be used to support the construction of the R&D platform and the fast promotion of the company's pipelines.
Read more
